Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

SURGE Therapeutics Stock

Q: How to sell SURGE Therapeutics stock?

If you hold private company shares of SURGE Therapeutics - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your SURGE Therapeutics stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

www.surgetx.com/Healthcare / BioTech & PharmaFounded: 2016

SURGE, The Intraoperative Immunotherapy Company™, envisions a world where all cancer patients undergoing tumor resection receive intraoperative immunotherapy to prevent recurrence and metastasis. Aiming to change the standard of care, SURGE focuses on transforming the deployment of cancer immunotherapy to improve survival outcomes dramatically. Their approach is dedicated to delivering focused immunotherapy treatments, redefining how, when, and where they are administered to cancer patients.

Buy or sell SURGE Therapeutics stockLearn more about SURGE Therapeutics IPO

OverviewFinancingsValuation

Enterprise Value

Access SURGE Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like SURGE Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

SURGE Therapeutics investors also invested in these private companies

Khosla Ventures

OpenAI, Waabi, Natron, Stripe, Synchron, Indiegogo, Hermeus, Ramp, Eat Just, Impossible Foods

8VC

ICON, Waabi, The Boring Company, Cognition, Sila Nanotechnologies, Flexport, Ramp, Relativity Space, Aviatrix, Mojo Vision

Alumni Ventures

Groq, OURA, Synchron, X-energy, Axiom Space, Ascend Elements, Capella Space, Lambda, Mythic, Frore Systems

Pitango Venture Capital

Graphcore, Formlabs, PsiQ, AI21 Labs, Riskified, SURGE Therapeutics

KdT Ventures

Abridge, SURGE Therapeutics, Checkerspot, Alkira

Bioluminescence Ventures

SURGE Therapeutics, Ensoma

Camford Capital

SURGE Therapeutics, Totus Medicines

Intuitive Ventures

Neocis, SURGE Therapeutics

The Institute of Cancer Research

SURGE Therapeutics

Team

Management Team

Michael Goldberg Ph.D

Founder, Chief Executive Officer & President

Charles Carignan MD

Chief Experience Officer

Board Members

Oliver Keown MD

Intuitive Ventures

SURGE Therapeutics stock FAQs

Can you buy SURGE Therapeutics stock?

As SURGE Therapeutics is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like SURGE Therapeutics, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy SURGE Therapeutics stock?

To invest in a private company like SURGE Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell SURGE Therapeutics stock?

Yes, you may be able to sell your SURGE Therapeutics stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell SURGE Therapeutics stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your SURGE Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is SURGE Therapeutics a public company?

No, SURGE Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is SURGE Therapeutics’ stock price?

SURGE Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access SURGE Therapeutics’ private market stock price with Forge Data.

What is SURGE Therapeutics’ stock ticker symbol?

SURGE Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

FORBES 07/19/2023

This Startup Just Raised $32 Million To Keep Cancers From Recurring After Surgery

On Wednesday, the company announced it has raised a $32 million series B round. The deal brings its total venture investments to $60 million. The company plans to use the new investment to continue development of its immunotherapy and to advance clinical trials for it.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.